Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn's Disease Patients with Prescription Claims for Ustekinumab in the USA.

Ding, Zhijie; Obando, Camilo; Muser, Erik; Kozma, Chris; Slaton, Terra

Ding, Zhijie; Obando, Camilo; Muser, Erik; Kozma, Chris; Slaton, Terra.

Ding Z; Janssen Scientific Affairs, LLC, Horsham, PA, USA. zding17@ITS.JNJ.com.
Obando C; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Muser E; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Kozma C; Independent Consultant, St Helena Island, SC, USA.
Slaton T; Independent Consultant, West Columbia, SC, USA.

Drugs Real World Outcomes ; 8(4): 565-575, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34136998

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2021 Tipo del documento: Article